Partner Headlines - BIIB

  1. Stock Indexes Mostly Flat; Time Warner Rises; Tesla Earnings ...

    Investors Business Daily
  2. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For ...

    Investors Business Daily
  3. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily
  4. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To ...

    Investors Business Daily
  5. Nasdaq Ends Near Record High; Oil Stocks Sink Dow, S&P 500

    Investors Business Daily
  6. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily
  7. Indexes Mixed As Oil Stocks Tumble; Alphabet Near High

    Investors Business Daily
  8. Nasdaq Poised To Surpass 5200; Other Indexes Lag On Oil Stock ...

    Investors Business Daily
  9. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch ...

    Investors Business Daily
  10. Ionis, Biogen Score Surprise Win Against Childhood Spinal Disease

    Investors Business Daily
  11. Stocks Open Narrowly Mixed; SolarCity Falls On Tesla Deal

    Investors Business Daily
  12. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or ...

    Investors Business Daily
  13. SPY ETF Posts Fourth Weekly Gain As Chip And Biotech Giants Surge

    Investors Business Daily
  14. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, ...

    Investors Business Daily
  15. Stocks Down At Midday; Biogen Leads Biotech Rebound

    Investors Business Daily
  16. Biogen CEO Quits Amid M&A Speculation; Company Hikes Outlook

    Investors Business Daily
  17. Investing Action Plan: Starbucks, AT&T, Chipotle, Biogen, Visa, ...

    Investors Business Daily
  18. John Paulson Bulks Up Health Care Bet

    GuruFocus
  19. Gilead, Johnson & Johnson or Roche?

    GuruFocus
  20. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist ...

    GuruFocus
  21. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  22. Former Leaders Show Up On New Low List; D.R. Horton Sinks Again

    IBD
  23. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD
  24. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD
  25. Maybe Some Good News For A Big Biotech ETF

    Benzinga
  26. Sobi to present new interim ASPIRE data at EAHAD congress suggesting ...

    Benzinga
  27. Earnings Recap For January 27

    Benzinga
  28. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga
  29. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga
  30. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga
  31. Earnings Scheduled For January 27, 2016

    Benzinga
  32. Big Earnings Expectations For Big Biotech

    Benzinga
  33. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga
  34. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing ...

    Benzinga
  35. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD
  36. This Week Is Paramount For Biotech Stocks

    Benzinga
  37. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus
  38. Jean Hynes Finds Her Pot of Gold

    GuruFocus
  39. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga
  40. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga
  41. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD
  42. Early Global News: Virtual Reality Market Getting Really Big, ...

    Benzinga
  43. Sanofi chips at Biogen share

    IBD
  44. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  45. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  46. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia ...

    Benzinga
  47. Stocks Quietly Higher; JD.com Clears Key Resistance

    IBD
  48. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  49. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus
  50. Biogen Among Murray Stahl's Holdings With Growing Earnings

    GuruFocus
  51. 10 S&P 500 Companies With Green Operations

    Benzinga
  52. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  53. Biogen's Breach Of 50-Day Line Was Clear Sell Signal

    IBD
  54. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus
  55. Biotechs Among Stocks That Insiders Have Been Buying Lately

    Benzinga
  56. Biogen Is a Bargain

    GuruFocus
  57. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  58. Apple Upgraded To Buy; Amazon, McDonald's PTs Hiked

    IBD
  59. Hurricane Hillary Shifts Left, Slamming More Stocks

    IBD
  60. Biogen tops Q3, will cut jobs

    IBD
  61. Biogen Volatile After Q3 Beat, Raised Guidance And Disappointing ...

    Benzinga
  62. Why Biogen Stock Is Having A Huge Day

    Benzinga
  63. Biogen Beats Q3 Views, Cuts Workforce, Lifts Guidance

    IBD
  64. Early Gains Fizzle, Turn Mixed; Biogen, Ferrari Rise

    IBD
  65. Benzinga's Top #PreMarket Gainers

    Benzinga
  66. Earnings Scheduled For October 21, 2015

    Benzinga
  67. Fast Money Picks For October 20

    Benzinga
  68. Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up

    Benzinga
  69. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD
  70. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  71. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  72. Market Has Overreacted in Biogen

    GuruFocus
  73. Frank Sands' Undervalued Holdings With Growing EPS

    GuruFocus
  74. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD
  75. Stocks Inch Up; Oil Gains Ease; Alcoa, Tesla, Gap Stumble

    IBD
  76. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD
  77. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD
  78. Will Fund Managers Pump Up Edwards To New Breakout?

    IBD
  79. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  80. Trans Pacific Trade Pact Finally Agreed

    Benzinga
  81. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  82. Fast Money Traders Share The Stocks They Would Buy In Fourth ...

    Benzinga
  83. Stocks Rally, Will Gains Hold? Biotechs Try Second Rebound

    IBD
  84. Stocks Mixed In Late Trade; Post Falls More

    IBD
  85. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness
  86. Roche Drug Scores A Hit Against Stubborn Form Of MS

    IBD
  87. Can Valeant Heal After Clinton Price-Gouging Tweet?

    IBD
  88. Can Valeant Heal After Clinton Price Gouging Tweet?

    IBD
  89. Biogen Approaches Support Levels In $290 Handle

    Benzinga
  90. Biotechs Are Getting Killed Because Of Hillary Clinton's Response ...

    Benzinga
  91. The Undervalued Stocks Among Richard Snow's Recent Buys

    GuruFocus
  92. Goldman Sachs' Stock Picks if Rates Rise

    FoxBusiness
  93. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  94. Biogen Licenses Mitsubishi Tanabe Pharma's MT-1303 for Autoimmune ...

    Benzinga
  95. Biogen: 'A Nice Little Trade' Or Heading To New Lows?

    Benzinga
  96. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    Benzinga
  97. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  98. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders ...

    GuruFocus
  99. Using ETFs To Run Your Own Hedge Fund

    Benzinga
  100. Morning Market Gainers

    Benzinga
Trading Center